Literature DB >> 2548287

[Experimental studies of healing process on compound blocks of hydroxyapatite (HAP) particles and tricalcium phosphate (TCP) powder implantation in rabbit mandible--comparison of HAP/TCP ratios and plastic methods].

Y Harada.   

Abstract

Bone substitutes consisting in 2 mold-poured compound blocks of HAP:TCP (mixing ratio 1:1) and HAP:TCP (mixing ratio 3:1) and one compound block (mixing ratio 1:1) prepared in a rubber press were implanted in defective areas in rabbit mandibles. The conditions under which the implants were made were identical in all cases. Histological studies and contact microradiography performed on ossification of the surfaces and surroundings of each block, ossification maturation, and the absorptive process of TCP and the extent to which it was replaced by new bone produced the following results. 1. At one week after surgery, new bone had grown along the surfaces of the blocks. It remained in tight contact with the block surfaces as it matured. These findings make it clear that the blocks are superior in terms of biocompatibility and osteoconduction. 2. In the course of time, in the 2 mold-poured compound blocks, the hydrated parts of alpha-TCP, which was a binder, were absorbed and replaced by new bone. At forty eight weeks after surgery, new bone had grown into the pores of the HAP particles to form a bone-HAP composite. 3. Even as late as forty eight weeks after surgery, some of the hydrated parts of alpha-TCP remained unabsorbed; and mold-poured compound blocks (mixing ratio 1:1) retained their shapes. On the other hand, in the mold-poured compound blocks (mixing ratio 3:1), the hydrated parts of alpha-TCP were almost absorbed and replaced by new bone in forty eight weeks after surgery. Amounts of the binder alpha-TCP present appeared to cause differences in biological reactions. 4. In the case of compound blocks of HAP:TCP (mixing ratio 1:1) formed in a rubber press, the binder was beta-TCP. Because of its high sintering properties and great density, absorption and ossification were gradual; and the blocks retained their complete original forms even in forty eight weeks after surgery. 5. Past reports have claimed that beta-TCP is absorbed in the initial stage. But, as is clear from experiments with compound blocks formed by means of a rubber press, even when the binder is beta-TCP in all cases, absorption speed differs depending on the mold used. 6. These results indicate that compound blocks of HAP and TCP used as artificial substitute bone materials have excellent properties of biocompatibility, osteoconduction, and plasticity. In addition, however, they make it clear that, owing to differences in absorption of the binder, ossification speed, and dynamic properties from block to block, it is essential to use the mold that properly suits conditions prevailing in the defective area.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548287

Source DB:  PubMed          Journal:  Shikwa Gakuho        ISSN: 0037-3710


  4 in total

1.  Synthesis and characterization of functional gradient materials using Indian corals.

Authors:  I Manjubala; M Sivakumar; T S Sampath Kumar; K Panduranga Rao
Journal:  J Mater Sci Mater Med       Date:  2000-11       Impact factor: 3.896

2.  Immuno-histopathologic evaluation of mineralized plasmatic matrix in the management of horizontal ridge defects in a canine model (a split-mouth comparative study).

Authors:  Souzy Kamal Anwar; Hend Mohamed Abdel Hamid
Journal:  Odontology       Date:  2022-01-05       Impact factor: 2.885

3.  Surface characteristics and bioactivity of a novel natural HA/zircon nanocomposite coated on dental implants.

Authors:  Ebrahim Karamian; Amirsalar Khandan; Mahmood Reza Kalantar Motamedi; Hesam Mirmohammadi
Journal:  Biomed Res Int       Date:  2014-04-16       Impact factor: 3.411

4.  A tri-component knee plug for the 3rd generation of autologous chondrocyte implantation.

Authors:  Lobat Tayebi; Zhanfeng Cui; Hua Ye
Journal:  Sci Rep       Date:  2020-10-12       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.